During the past decade, Marc Righini conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marc Righini" #1 collaborator was "Swiss National Science Foundation" with 1 trials as a collaborator, "The Ottawa Hospital" with 1 trials as a collaborator, "University Hospital, Brest" with 1 trials as a collaborator and "University Medical Center Groningen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Marc Righini" are "Deep Vein Thrombosis" (2 trials), "D-dimer" (1 trials) and "Pulmonary Embolism" (1 trials). Many other conditions were trialed in "Marc Righini" in a lesser frequency.

Most popular intervention types in "Marc Righini" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pregnant patients with suspected PE will undergo a strategy based on clinical probability assessment, D-dimer, lower limb vein ultrasonography and MSCT." (1 trials) and "Three-month thromboembolic risk in patient with D-dimer levels between the usual cut-off and the age-adjusted cut-off" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marc Righini" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Marc Righini". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Marc Righini, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marc Righini, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".